Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Sodium aurothiomalate
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Sodium aurothiomalate 50mg/0.5ml inj ampoules
1001030J0AAAEAE
|
Sodium aurothiomalate | Sodium aurothiomalate | Musculoskeletal and Joint Diseases | 2 |
|
Myocrisin 10mg/0.5ml solution for injection ampoules
1001030J0BBACAC
|
Myocrisin | Sodium aurothiomalate | Musculoskeletal and Joint Diseases | 1 |
|
Myocrisin 20mg/0.5ml solution for injection ampoules
1001030J0BBADAD
|
Myocrisin | Sodium aurothiomalate | Musculoskeletal and Joint Diseases | No data available |
|
Myocrisin 50mg/0.5ml solution for injection ampoules
1001030J0BBAEAE
|
Myocrisin | Sodium aurothiomalate | Musculoskeletal and Joint Diseases | No data available |
|
Sodium aurothiomalate 10mg/0.5ml inj ampoules
1001030J0AAACAC
|
Sodium aurothiomalate | Sodium aurothiomalate | Musculoskeletal and Joint Diseases | No data available |
|
Sodium aurothiomalate 20mg/0.5ml inj ampoules
1001030J0AAADAD
|
Sodium aurothiomalate | Sodium aurothiomalate | Musculoskeletal and Joint Diseases | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.